v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Information  
Schedule of segment reporting information, by segment

 

Three Months Ended March 31,

 

2026

 

2025

 

Biopharma Division

 

Neuromodulation Division

 

Total

 

Biopharma Division

 

Neuromodulation Division

 

Total

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Personnel and related expenses

$

2,610

 

$

390

 

$

3,000

 

$

2,473

 

$

221

 

$

2,694

Office space rental related expenses

 

1,128

 

 

30

 

 

1,158

 

 

1,063

 

 

110

 

 

1,173

Development expenses

 

1,008

 

 

-

 

 

1,008

 

 

827

 

 

-

 

 

827

Professional services and insurance

 

1,058

 

 

220

 

 

1,278

 

 

1,317

 

 

232

 

 

1,549

Depreciation and amortization

 

130

 

 

-

 

 

130

 

 

99

 

 

4

 

 

103

Other general and administrative expenses

 

287

 

 

86

 

 

373

 

 

162

 

 

49

 

 

211

Other income (expense), net

 

(209)

 

 

42

 

 

(167)

 

 

(296)

 

 

41

 

 

(255)

Segment net loss

$

6,012

 

$

768

 

$

6,780

 

$

5,645

 

$

657

 

$

6,302